Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United States.

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood product specialist remains hopeful that Hemgenix is here to stay. “I hope ...

New treatments for Prader-Willi Syndrome and hemophilia; FDA fast tracks a chlamydia vaccine candidate; over-the-counter test cleared for identifying chlamydia, gonorrhea and trichomoniasis.

Belief BioMed ("BBM") and Takeda China today jointly announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the National Medical Products ...

More than 40% of the 225 scientists and public health workers at the CDC's National Center on Birth Defects and Developmental ...

The American Society of Hematology (ASH) and nearly 100 other organizations blasted the dismantling of CDC's Division of ...

Health Canada approved Altuviiio to treat hemophilia A in children, adolescents, and adults with the condition.

My new book examines the life, death, and legacies of Ryan White, the Indiana teenager with hemophilia who contracted HIV ...

Many people don't think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it's no small matter ...

In this cohort of individuals with hemophilia, the physical activity levels and step count did not significantly differ between severity phenotypes. Evidence Rating Level: 1 (Excellent) Hemophilia is ...